| Literature DB >> 32527334 |
Palaniappan Ganesh Nagappan1, Hong Chen2, De-Yun Wang3.
Abstract
Neuronal networks, especially those in the central nervous system (CNS), evolved to support extensive functional capabilities while ensuring stability. Several physiological "brakes" that maintain the stability of the neuronal networks in a healthy state quickly become a hinderance postinjury. These "brakes" include inhibition from the extracellular environment, intrinsic factors of neurons and the control of neuronal plasticity. There are distinct differences between the neuronal networks in the peripheral nervous system (PNS) and the CNS. Underpinning these differences is the trade-off between reduced functional capabilities with increased adaptability through the formation of new connections and new neurons. The PNS has "facilitators" that stimulate neuroregeneration and plasticity, while the CNS has "brakes" that limit them. By studying how these "facilitators" and "brakes" work and identifying the key processes and molecules involved, we can attempt to apply these theories to the neuronal networks of the CNS to increase its adaptability. The difference in adaptability between the CNS and PNS leads to a difference in neuroregenerative properties and plasticity. Plasticity ensures quick functional recovery of abilities in the short and medium term. Neuroregeneration involves synthesizing new neurons and connections, providing extra resources in the long term to replace those damaged by the injury, and achieving a lasting functional recovery. Therefore, by understanding the factors that affect neuroregeneration and plasticity, we can combine their advantages and develop rehabilitation techniques. Rehabilitation training methods, coordinated with pharmacological interventions and/or electrical stimulation, contributes to a precise, holistic treatment plan that achieves functional recovery from nervous system injuries. Furthermore, these techniques are not limited to limb movement, as other functions lost as a result of brain injury, such as speech, can also be recovered with an appropriate training program.Entities:
Keywords: Central nervous system; Neuronal systems; Neuroregeneration; Peripheral nervous system; Plasticity; Postinjury; Rehabilitation
Year: 2020 PMID: 32527334 PMCID: PMC7288425 DOI: 10.1186/s40779-020-00259-3
Source DB: PubMed Journal: Mil Med Res ISSN: 2054-9369
Fig. 1Extrinsic and intrinsic factors that affect neuroregeneration in the central and peripheral nervous systems. PTEN. Phosphatase and tensin homolog; SOCS3. Suppressor of cytokine signaling 3; NGF. Nerve growth factor; MAG. Myelin-associated glycoprotein; Omgp. Oligodendrocyte.myelin glycoprotein; CSPG. Chondroitin sulfate proteoglycans; KSPG. Keratin sulfate proteoglycans
Fig. 2Cascade of reactions from a calcium burst and methods of activating regeneration-associated genes (RAGs). MAPKKK dlk1. Mitogen-activated protein kinase kinase kinase dlk-1; pErk. Phosphorylated extracellular signal-regulated protein kinases; HDAC5. Histone Deacetylase 5; RAGs. Regeneration associated genes; PTEN. Phosphatase and tensin homolog; PI3K. Phosphoinositide 3-kinases; AKT. Protein kinase B; mTORC1. Mammalian target of rapamycin complex 1 or mechanistic target of rapamycin complex 1; SOCS3. Suppressor of cytokine signaling 3; JAK/STAT 3. Janus kinase/signal transducer and activator of transcription 3
Fig. 3Nogo-A mechanism of action. Nogo-A interacts with several receptors, the most important of which are NgR1, LINGO1 and p75/TROY. This interaction creates a cascade that inhibits neuroregeneration in the nerve cell growth cones. LINGO1. Leucine rich repeat and Immunoglobin-like domain-containing protein 1; p75. Neurotrophin receptor; TROY. Tumor necrosis factor receptor superfamily, member 19; RhoA. Ras homolog family member A
Proteins in the CNS extracellular matrix that contribute to the inhibition of neuroregeneration after injury
| Inhibitory protein | Function | Complementary receptors |
|---|---|---|
| Nogo-A | Remyelination inhibitor via the RhoA pathway | Nogo-66 terminus: NgR1, p75, TROY and LINGO1 Amino-Nogo terminus: unknown |
| MAG | Remyelination inhibitor via the RhoA pathway | NgR2, GT1b, NgR1, p75, TROY and LINGO1 |
| OMgp | Remyelination inhibitor via the RhoA pathway | NgR1 |
| Versican (CSPG2) | Important during inflammation as it interacts with inflammatory leukocytes and inflammatory cells recruiting chemokines. It also stabilizes perineuronal nets to stabilize synaptic connections. | N-terminus: hyaluronan in the extracellular matrix (ECM) C-terminus: Ligands in ECM, especially tenascin [ |
| NI-35 | Nonpermissive growth factor in myelin | Unknown |
| Ephrin B3 [ | Inhibits remyelination | EphA4 |
| Semaphorin 4D (Sema 4D) [ | Inhibits remyelination | PlexinB1 |
| Semaphorin 3A (Sema 3A) [ | In scars in both PNS and CNS injuries | Nrp1, Nrp2, L1cam, Nrcam [ |
NgR1 Neuronal Nogo-66 receptor 1, LINGO1 Leucine rich repeat and Immunoglobin-like domain-containing protein 1, p75 neurotrophin receptor, TROY Tumor necrosis factor receptor superfamily, member 19, RhoA Ras homolog family member A, MAG Myelin-associated glycoprotein, GT1b Trisialoganglioside protein, OMgp Oligodendrocyte-myelin glycoprotein, CSPG2 chondroitin sulfate proteoglycan core protein 2 or versican, ECM extracellular matix, NI-35 A CNS myelin-associated neurite growth inhibitor, EphA4 Ephrin type-A receptor 4, Nrp1 Neuropilin 1, Nrp2 Neuropilin 2, L1cam L1 cell adhesion molecule, Nrcam Neuronal cell adhesion molecule
Rehabilitative potential for different areas of the nervous system damaged by blast or gunshot injuries
| Areas for rehabilitation improvement | Affected area | Methods that can be used with observed impacts |
|---|---|---|
| Movement disorders in Parkinson’s Disease | Basal ganglia [ | • Long-term deep brain stimulation of the subthalamic nuclei • Restorative effects of global structural and functional connectivity as a result of plasticity and neuroregeneration [ • Stimulation of mesencephalic locomotor region [ |
| Motor recovery after stroke | Unilateral cervical contusion [ | • Vagal nerve stimulation • Release of monoamines within cerebral cortex • Promotes plasticity of neural circuits and enhances motor learning [ • Activity-dependent plasticity also occurs [ |
| Allodynia | Mid-thoracic contusion SCI [ | • Induces plasticity via stimulation to the nucleus raphe magnus to augment serotonin release [ |
| Speech | Left fronto-temporo-parietal region (15708219) | • Intensive speech therapy [ • Combined with pharmacological therapies [ • Combined with noninvasive brain stimulation [ • Results are promising, but sample sizes have been small [ |
| Eating and swallowing | Motor cortex | • Sensory input essential as it drive changes in cortical circuitry [ • Neuromuscular stimulation induces plasticity changes [ |
| Visual field and recognition | Visual cortex | • Restitutive capacity is limited [ • Compensatory mechanism are effective – shifting the visual field border towards the hemianopic side in hemianopia to improve spatial orientation and mobility [ • New visual functions – enhancement of the resolution to make it greater than that of the retina [ • Plasticity level in higher visual functions is unknown [ • Plasticity through cross-mode sharing of visual pathways with tactile or auditory pathways through extensive training and practice [ |
| Optic Nerve | • Optic nerve with appropriate deletions of physiological “brakes” or additions of “facilitators” can regenerate centrally from the retinal ganglion cells [ | |
| Cognitive (thinking, reasoning, judgment and memory) | Frontal cortex | • NF training can lead to positive memory function and normalization of pathological brain activation patterns [ • Enriched environment promotes synaptic plasticity [ • Selective serotonin reuptake inhibitors administered acutely after brain injury may induce plasticity similar to that seen in the critical period [ • Normal plasticity becomes dysfunctional postinjury, failing to confer neuroprotection and to prevent further cell death. Therapies should target aspects of normal plasticity that are altered postinjury [ |
| Bowel and bladder control | SCI above the sacrum | • Early sacral neuromodulation following SCI reduces the extent of secondary injury and maladaptive neural restricting [ • Further evidence needed to support this theory. • EGFR inhibition promotes nerve regeneration in vitro and in vivo, with bladder function restored in rodents [ |
| Emotional control | Fear memories | • Inhibition of NgR1 can help with the recovery of emotional control postinjury [ |
NF Neurofeedback, SCI Spinal Cord Injury, EGFR epidermal growth factor receptor, NgR1 Neuronal Nogo-66 receptor 1